In clinical practice, Glutathione injections are commonly used in modest doses on a recurring schedule, such as weekly or multiple times per week, depending on individual needs and tolerance
They should not be used by: People with a history of pancreatitis (inflammation of the pancreas) Anyone with a personal or family history of medullary thyroid cancer (a rare type of thyroid cancer) People with multiple endocrine neoplasia type 2 (MEN 2, a rare inherited condition that raises the risk of certain hormone-related tumors, including thyroid cancer) Women who are pregnant or breastfeeding People with severe stomach or bowel problems, such as gastroparesis (slow stomach emptying that causes nausea, fullness, or vomiting) or inflammatory bowel disease (chronic inflammation of the digestive tract, such as Crohns disease or ulcerative colitis) Those with severe kidney problems, especially with certain types of GLP-1 medicines, such as exenatide Anyone with allergies to GLP-1 medications or who has had a severe reaction to them Use in children is limited to certain GLP-1 medicines approved for adolescents with obesity
When used for obesity, these medications are usually given in higher doses than when given for type 2 diabetes
Hernandez combines evidence-based metabolic medicine with pediatric endocrinology, nutrition, exercise physiology, behavioral health, and personalized lifestyle interventions to help children build healthier metabolism and lifelong wellness
There is consistent evidence from epidemiologic studies in populations exposed to high arsenic concentrations in drinking water that people who can efficiently convert inorganic arsenic to DMA are at lower risk for arsenic-induced disease than those who are poor methylators, who have higher proportions of MMA and inorganic arsenic in urine
